74 related articles for article (PubMed ID: 15483737)
21. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
[TBL] [Abstract][Full Text] [Related]
22. [Adalat in the treatment of intractable angina].
Ceremuzyński L; Zalewski A; Borkowska J; Czarniak S; Czerska J; Sulikowska A
Pol Tyg Lek; 1979 Apr; 34(15):589-91. PubMed ID: 450773
[No Abstract] [Full Text] [Related]
23. Effectiveness of nifedipine GITS in combination with atenolol in chronic stable angina.
Toal CB; Motro M; Baird MG; Klinke P; Sclarowski S; Zilberman A; Marmor A; Kostuk WJ; Lotan C; Weiss A; Erne P; Palant A; Stolero D; Bélanger L; Turpie A
Can J Cardiol; 1999 Oct; 15(10):1103-9. PubMed ID: 10523477
[TBL] [Abstract][Full Text] [Related]
24. Nifedipine plasma concentration in patients treated for angina pectoris.
Stern Z; Zylber-Katz E; Levy M
Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):198-203. PubMed ID: 6715089
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
Fagan TC; Haggert BE; Liss C
Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
[TBL] [Abstract][Full Text] [Related]
26. Effects of adalat (nifedipine) on left ventricular hemodynamics in angina pectoris: comparative study with propranolol.
Kurita A; Ogawa T; Kanazawa M; Hamamato H; Mabuchi G
Br J Clin Pract Suppl; 1980; 8():32-6. PubMed ID: 6781515
[No Abstract] [Full Text] [Related]
27. Design and current status of ACTION: A Coronary disease Trial Investigating Outcome with Nifedipine GITS. Gastro-Intestinal Therapeutic System.
Lubsen J; Poole-Wilson PA; Pocock SJ; van Dalen FJ; Baumann J; Kirwan BA; Parker AB
Eur Heart J; 1998 Aug; 19 Suppl I():I20-32. PubMed ID: 9743440
[TBL] [Abstract][Full Text] [Related]
28. Added benefits of nifedipine (Adalat GITS) beyond lowering blood pressure.
Cardiovasc J S Afr; 2004; 15(4):198-9. PubMed ID: 15322581
[No Abstract] [Full Text] [Related]
29. Safety of nifedipine GITS in stable angina: the ACTION trial.
Poole-Wilson PA; Kirwan BA; Vokó Z; de Brouwer S; van Dalen FJ; Lubsen J;
Cardiovasc Drugs Ther; 2006 Feb; 20(1):45-54. PubMed ID: 16552473
[TBL] [Abstract][Full Text] [Related]
30. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
[TBL] [Abstract][Full Text] [Related]
31. The ACTION study: nifedipine in patients with symptomatic stable angina and hypertension.
Sierra C; Coca A
Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1055-62. PubMed ID: 18793108
[TBL] [Abstract][Full Text] [Related]
32. P&T Committee review of nifedipine GITS: new modality for angina and hypertension.
Weintraub M; Horn J; Krakoff L; Vetrovec G
Hosp Formul; 1990 Mar; 25 Suppl A():10-4. PubMed ID: 10103975
[TBL] [Abstract][Full Text] [Related]
33. [Long-term clinical study of a new molecule (nifedipine) in ischemic cardiopathy].
Cafiero M; Sensale P; Buono G
Minerva Med; 1977 Jun; 68(32):2275-84. PubMed ID: 406586
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of nifedipine therapy in patients with refractory angina pectoris: significance of the presence of coronary vasospasm.
Stone PH; Muller JE; Turi ZG; Geltman E; Jaffe AS; Braunwald E
Arq Bras Cardiol; 1983 Dec; 41(6):469-76. PubMed ID: 6431950
[No Abstract] [Full Text] [Related]
35. Relative bioavailability of four controlled-release nifedipine products.
Schall R; Müller FO; Hundt HK; Duursema L; Groenewoud G; Van Dyk M; Van Schalkwyk AM
Biopharm Drug Dispos; 1994 Aug; 15(6):493-503. PubMed ID: 7993987
[TBL] [Abstract][Full Text] [Related]
36. Action: a 30,000 patient-years double-blind, placebo-controlled trial of nifedipine GITS in stable angina. ACTION Research Group.
Lubsen J; Poole-Wilson PA
Br J Clin Pract Suppl; 1997 Apr; 88():23-6. PubMed ID: 9519504
[TBL] [Abstract][Full Text] [Related]
37. Benefits of nifedipine GITS in stable coronary artery disease: Further analysis of the "ACTION" database.
Meredith PA; Elliott HL
Adv Ther; 2010 May; 27(5):297-306. PubMed ID: 20490733
[TBL] [Abstract][Full Text] [Related]
38. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Bakker J; Grover R; McLuckie A; Holzapfel L; Andersson J; Lodato R; Watson D; Grossman S; Donaldson J; Takala J;
Crit Care Med; 2004 Jan; 32(1):1-12. PubMed ID: 14707554
[TBL] [Abstract][Full Text] [Related]
39. [Results of a field trial of the coronary drug Adalat (BAY a 1040)].
Dünschede HB; Grundei P
Med Welt; 1975 Oct; 26(40):1847-50. PubMed ID: 1102835
[No Abstract] [Full Text] [Related]
40. [Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris].
Verdecchia P
Minerva Cardioangiol; 1993 Sep; 41(9):349-63. PubMed ID: 7903118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
